Penetrance of eye defects in mice heterozygous for mutation of Gli3 is enhanced by heterozygous mutation of Pax6 by Zaki, Paulette A et al.
BioMed  Central
Page 1 of 11
(page number not for citation purposes)
BMC Developmental Biology
Open Access Research article
Penetrance of eye defects in mice heterozygous for mutation of Gli3 
is enhanced by heterozygous mutation of Pax6
Paulette A Zaki1, J Martin Collinson2, Junko Toraiwa1, T Ian Simpson1, 
David J Price*1 and Jane C Quinn1
Address: 1Genes and Development Group, University of Edinburgh, Hugh Robson Building, George Square, Edinburgh, EH8 9XD, UK and 2School 
of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK
Email: Paulette A Zaki - paulettezaki@hotmail.com; J Martin Collinson - m.collinson@abdn.ac.uk; Junko Toraiwa - J.Toraiwa@sms.ed.ac.uk; T 
Ian Simpson - Ian.Simpson@ed.ac.uk; David J Price* - David.Price@ed.ac.uk; Jane C Quinn - Jane.Quinn@ed.ac.uk
* Corresponding author    
Abstract
Background: Knowledge of the consequences of heterozygous mutations of developmentally
important genes is important for understanding human genetic disorders. The Gli3 gene encodes a
zinc finger transcription factor and homozygous loss-of-function mutations of Gli3  are lethal.
Humans heterozygous for mutations in this gene suffer Greig cephalopolysyndactyly or Pallister-
Hall syndromes, in which limb defects are prominent, and mice heterozygous for similar mutations
have extra digits. Here we examined whether eye development, which is abnormal in mice lacking
functional Gli3, is defective in Gli3+/- mice.
Results: We showed that Gli3 is expressed in the developing eye but that Gli3+/- mice have only
very subtle eye defects. We then generated mice compound heterozygous for mutations in both
Gli3 and Pax6, which encodes another developmentally important transcription factor known to be
crucial for eye development. Pax6+/-; Gli3+/- eyes were compared to the eyes of wild-type, Pax6+/-
or Gli3+/- siblings. They exhibited a range of abnormalities of the retina, iris, lens and cornea that
was more extensive than in single Gli3+/- or Pax6+/- mutants or than would be predicted by addition
of their phenotypes.
Conclusion: These findings indicate that heterozygous mutations of Gli3 can impact on eye
development. The importance of a normal Gli3 gene dosage becomes greater in the absence of a
normal Pax6 gene dosage, suggesting that the two genes co-operate during eye morphogenesis.
Background
The zinc-finger transcription factor Gli3 is required for
normal limb, brain and eye development. In humans, a
number of different mutations to the GLI3 allele can cause
Greig cephalopolysyndactyly (GCPS) or Pallister-Hall
Syndrome (PHS) [1,2]. Clinical features of GCPS include
polydactyly, syndactyly, ocular hypertelorism and macro-
cephaly; those of PHS include polydactyly, imperforate
anus, renal abnormalities, hypothalamic hamartoma and
pituitary dysplasia. Mutations of the Gli3 gene in mice
cause the extra-toes (Xt) phenotype [3]. Johnson [4] first
reported a comprehensive analysis of the developmental
anatomy of Xt mice. Homozygotes die by birth and the
most prominent defects are found in the distal limbs, in
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rostral portions of the head including the forebrain and
eyes (see below), along the ventral midline of the thorax
and along the midline of the visceral ectoderm. Heterozy-
gotes are described as developing relatively normally in all
respects bar the formation of an extra digit, or digit-like
appendage, on either the fore- or hindlimbs.
The vertebrate transcription factors Gli1, Gl2 and Gli3 are
homologues of the Drosophila transcription factor cubitus
interruptus [5]. These transcription factors transduce the
responses of cells to diffusible morphogens of the Hedge-
hog family in both vertebrates and invertebrates [6].
Although Gli3 may have an early activator function in ver-
tebrates [7], it is thought that its main actions are to
repress the expression of sonic hedgehog (Shh) target
genes. Thus, loss of Gli3 in mice that also lack Shh can
reverse many of the defects associated with reduced
hedgehog signalling [8], presumably because loss of Gli3
allows the reactivation of Shh target genes.
With regards the requirement for Gli3 in eye develop-
ment,Gli3-/- embryos exhibit a variety of eye abnormalities
ranging from microphthalmia to the absence of any rem-
nant of eye tissue [4,7,9-11]. Most likely these defects
stem from interference with normal Shh signalling, which
is essential for normal initiation of eye development [12]
and later neural retinal development [13]. The extent to
which a normal gene dosage of Gli3 is needed for eye
development is not clear. The only eye defect described in
mice heterozygous for mutations in Gli3 is the presence of
folded retinae in a proportion of neonatal animals [4]. In
the present study, we characterized the eye phenotype of
Gli3+/- mice and identified previously undescribed defects
that were subtle. We then considered whether the require-
ment for a normal dosage of Gli3 might be greater if the
gene dosage for another transcription factor known to be
critical for eye development was to be reduced.
Extensive work on Pax6 has highlighted the important
role that this molecule plays in both invertebrate and ver-
tebrate eye development [e.g. reviewed in [14,15]]. Muta-
tions within the Pax6  gene cause eye abnormalities in
both mouse and man [16,17]. Mice homozygous for null
mutations in the Pax6 gene fail to form eyes [16,18,19]
whereas mice heterozygous for Pax6  mutations exhibit
microphthalmia and have hypoplastic irises and multiple
anterior segment defects [19-22]. There is evidence that
Pax6 is both regulated by and regulates expression of Shh
in brain tissue: Shh has been shown to repress Pax6
expression [23] and loss of Pax6 in mutant mice causes an
upregulation of Shh expression [24-26]. Thus, reduction
of either Pax6 or Gli3 levels might be predicted to affect
eye development by activation, through different mecha-
nisms, of Shh signalling. When we compared Pax6+/-;
Gli3+/- eyes to the eyes of wild-type, Pax6+/- or Gli3+/- sib-
lings we observed a range of abnormalities more extensive
than in Gli3+/- or Pax6+/- mutants or than would be pre-
dicted by addition of their phenotypes.
Results
Overlapping expression of Pax6 and Gli3 in the developing 
eye
As shown in Fig. 1A,B, Pax6 and Gli3 are expressed in the
prenatal mouse eye [see also [5,18,27,28]]. Both genes are
expressed in the neural retina, retinal pigment epithelium,
lens and surface ectoderm.
General development of the eye in Gli3+/-, Pax6+/- and 
Gli3+/-; Pax6+/- mutants
The appearances of E14.5 Gli3+/-, Pax6+/- and Gli3+/-;Pax6+/
- eyes, immunostained for Pax6 expression, are shown in
Fig. 1C–E. Pax6 immunoreactivity was seen in the devel-
oping neural retina, retinal pigment epithelium, lens and
surface ectoderm in all geneotypes, as in wild-types. There
were, however, differences in morphology.
The E14.5 Gli3+/- eyes appeared slightly larger than those
of wild-type siblings, although their appearances were
otherwise normal (Fig. 1C). The E14.5 Pax6+/-  eyes
appeared smaller than those of wild-type siblings (Fig.
1D) and Pax6 protein was seen in cells forming a lens-cor-
neal bridge (arrowhead in Fig. 1D), as described previ-
ously [22]. The sizes of E14.5 Pax6+/-; Gli3+/- eyes were
more variable than those of siblings of the other three
genotypes; many were similar to those of Pax6+/- eyes (Fig.
1E). Pax6+/-; Gli3+/- eyes showed more obvious abnormal-
ities than eyes of the other genotypes, including dysplasia
at the most distal tips of the retina causing ectopic retinal
tissue within the presumptive anterior chamber (Fig. 1E).
We then examined the overall mass of eyes of the different
genotypes in adults (Fig. 2). Similar to previous studies
[22], we found that the average mass of Pax6+/- eyes (18.1
± 0.2 mg, sd = 1.0, σ2 = 1.0, n = 24) was significantly less
than that of wild-type eyes (24.7 ± 0.4 mg, sd = 1.8, σ2 =
3.4, n = 18) (P < 0.001, Student's t-test) (Fig. 2). The aver-
age mass of Gli3+/- eyes was slightly, but significantly,
larger than that of wild-type eyes (26.1 ± 0.3 mg, sd = 1.8,
σ2 = 3.1, n = 30; P = 0.016, Student's t-test) (Fig. 2). The
average mass of Pax6+/-; Gli3+/-eyes (19.3 ± 0.8 mg, sd =
4.1, σ2 = 16.7, n = 25) was significantly less than that of
wild-type eyes (P < 0.001, Student's t-test), but not signif-
icantly different to that of Pax6+/- eyes. There was much
greater variation than among eyes of the other genotypes
(Fig. 2). Whereas only 1/24 Pax6+/- eyes fell within the
range for wild-type eyes, 12/25 of Pax6+/-; Gli3+/- eyes fell
within the wild-type range and 4/25 eyes weighed less
than the smallest mass observed in the Pax6+/- group (Fig.
2).BMC Developmental Biology 2006, 6:46 http://www.biomedcentral.com/1471-213X/6/46
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Pax6+/-; Gli3+/- animals exhibit severe retinal abnormalities
No retinae from wild-type littermates of our mutant ani-
mals showed any overt abnormalities (Fig. 3A). The
majority of Gli3+/- animals (22/25) showed no retinal dys-
plasia (Fig. 3B); a small proportion (3/25) did exhibit
focal retinal hyperplasia (Fig. 3E). No retinal dysplasia
was observed in any of the Pax6+/- eyes studied (Fig. 3C)
(n = 14). Pax6+/-; Gli3+/- retinae fell into 2 categories. 1)
Some retinae exhibited no dysplasia but were thinner
than those of other genotypes (15/28) (Fig. 3D). 2) Some
retinae were dysplastic (13/28) (Fig. 3F–H) with areas
where lamination was completely disrupted with loss of
any defined retinal organisation and mixing of the nuclear
layers.
We compared retinal thicknesses in the positions shown
in Fig. 4A in wild-type, Pax6+/-, Gli3+/- and Pax6+/-;Gli3+/-
animals. Compound heterozygotes that had retinal dys-
plasia in the regions measured were excluded. Whole reti-
nal thickness was significantly reduced in Pax6+/-;Gli3+/-
animals compared to their wild-type, Pax6+/- and Gli3+/-
siblings, all of which had similar thicknesses (Fig. 4B).
We then examined which retinal layers were most affected
in Pax6+/-; Gli3+/- retinae. The adult neural retina is divided
into 5 layers: the outer nuclear layer (ONL), the outer
plexiform layer (OPL), the inner nuclear layer (INL), the
inner plexiform layer (IPL) and the ganglion cell layer
(GCL). We found that the thicknesses of both the ONL
(A) Gli3 mRNA expression in the developing eye at E14.5 Figure 1
(A) Gli3 mRNA expression in the developing eye at E14.5. mRNA expression is observed in the neural retinal, retinal pigment 
epithelium, lens and surface ectoderm. (B-E) Pax6 protein expression in (B) wild type, (C)Gli3+/-, (D) Pax6+/- and (E) Pax6+/-; 
Gli3+/- eyes. In wild type embyos (B), Pax6 is expressed in cells of the neural retina, lens epithelium and surface ectoderm. Gli3+/
-embryos (C) show identical Pax6 expression to wild type with no overt retinal dysmorphology. Eyes of the developing Pax6+/- 
embryo (D) show a similar Pax6 expression to wild type but cells forming the persistent lens stalk (arrow) can be clearly seen 
to be Pax6 expressing. Pax6+/-;Gli3+/- eyes (E) exhibit Pax6 expression localised to the neural retina, retinal pigment epithelium 
and lens epithelium but show overt distal retinal dysplasia. Rpe, retinal pigment epithelium; nr, neural retina; L, lens; se, surface 
ectoderm. Scale bar = 200 μm.BMC Developmental Biology 2006, 6:46 http://www.biomedcentral.com/1471-213X/6/46
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and INL of Pax6+/-;  Gli3+/-  retinae were significantly
reduced compared to those of the other genotypes (Fig.
4C,D). In some Pax6+/-; Gli3+/- retinae (3/21), the OPL was
not discernible; where this layer was present, its average
thickness was not significantly different to that of wild-
type animals (Fig. 4E). Interestingly, the OPLs of both
Pax6+/- and Gli3+/- retinae were thicker than those of wild-
type and Pax6+/-; Gli3+/- animals (Fig. 4E). The IPL of the
Pax6+/-; Gli3+/- retina was significantly thinner than that of
wild-type and Gli3+/- retinae, but was not significantly dif-
ferent to that of Pax6+/- animals (Fig. 4F), which was itself
significantly thinner than that of wild-types (Fig. 4F). As
the GCL is only one cell thick, measurement was not done
on this layer. We did not, however, observe any obvious
defects in the GCL in any of the genotype groups. Overall,
we concluded that the thicknesses of the retina and most
of its layers are severely compromised in Pax6+/-; Gli3+/-
animals but not in Pax6+/- or Gli3+/- siblings.
Anterior segment and lens defects in Pax6+/-; Gli3+/- 
animals
Consistent with previous studies [22], we observed lens-
corneal adhesions with cellular bridges in Pax6+/- embry-
onic (Fig. 1D) and adult eyes (Table 1). Lens-corneal
adhesions were found with a similar incidence in Pax6+/-;
Gli3+/- eyes (Table 1). We observed several other types of
abnormal contact in Pax6+/-; Gli3+/- eyes, which were not
found in wild-type, Pax6+/- or Gli3+/- eyes in our sample.
These were common between the cornea and iris (Fig.
5A,B) but were also seen between retina and lens and iris
and retina (Table 1). Some Gli3+/- eyes showed small
Retinal morphology of wild-type (A), Gli3+/- (B, E), Pax6+/- (C) and Pax6+/-;Gli3+/- (D, F-H) animals Figure 3
Retinal morphology of wild-type (A), Gli3+/- (B, E), Pax6+/- (C) and Pax6+/-;Gli3+/- (D, F-H) animals. Although a majority of Gli3+/- 
retinae exhibit normal lamination (B), mild focal dysplasia is seen (E). Pax6+/-; Gli3+/- retinal phenotypes include thinning of the 
retina (D) and dysplasia (F-H). gcl, ganglion cell layer; inl, inner nuclear layer; onl, outer nuclear layer; ipl, inner plexiform layer; 
opl, outer plexiform layer; r, rosette. Scale bars = 100 μm.
Masses of wild-type (n = 18), Gli3+/- (n = 30), Pax6+/- (n = 24)  and Pax6+/-; Gli3+/- (n = 25) adult eyes Figure 2
Masses of wild-type (n = 18), Gli3+/- (n = 30), Pax6+/- (n = 24) 
and Pax6+/-; Gli3+/- (n = 25) adult eyes.
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Retinal layer thickness in wild-type, Gli3+/-, Pax6+/- and Pax6+/-; Gli3+/- eyes Figure 4
Retinal layer thickness in wild-type, Gli3+/-, Pax6+/- and Pax6+/-; Gli3+/- eyes. (A) Schematic representation of areas of retinal layer 
measurements in wild-type and mutant eyes. Measurement of retinal layers for (B) whole retinal thickness, (C) outer nuclear 
layer (ONL), (D) inner nuclear layer (INL), (E) outer plexiform layer (OPL), (F) inner plexiform layer (IPL) showing average 
thickness (μm) (+/- s.e.m.) for each genotype group. Significant differences between genotypes are shown with brackets. l, lens; 
r, retina; on, optic nerve. * P = < 0.05; ** P = 0.001.
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points of contact between the iris and lens (Fig. 5F; Table
1); these were not seen in Pax6+/-eyes and were more fre-
quent and extensive in Pax6+/-; Gli3+/- eyes (Table 1). We
can not be sure of the exact nature of these contacts, but
the fact that we did not observe them in wild-type eyes
suggests that they reflect real defects in the interactions
between different parts of the eye.
Many Pax6+/-; Gli3+/- eyes exhibited highly dysgenic hyper-
plastic irises (12/28) (Fig. 5A,B), which were not observed
Anterior segment abnormalities in Pax6+/-; Gli3+/- eyes Figure 5
Anterior segment abnormalities in Pax6+/-; Gli3+/- eyes. Abnormal contacts between cornea and iris (A-C), lens and cornea (E) 
and iris and lens (D) were observed in Pax6+/-; Gli3+/- eyes. (A-C) Iris hyperplasia and formation of cyst-like structures involving 
iris, retina and cornea were also observed (C). (D, E) Some lenses of Pax6+/-; Gli3+/- animals were highly dysgenic. Some Gli3+/- 
animals had iris tissue attached to the lens (arrow in F). i, iris; cs, corneal stroma; L, lens; c, cyst. Scale bars = 100 μm.
Table 1: Incidence of abnormal contacts between different tissues in the eyes of wild-type, Gli3+/-, Pax6+/- and Pax6+/-; Gli3+/- animals.
Genotype Eyes n = Cornea-lens Cornea-iris Iris-lens Retina-lens Iris-retina
Wt 17 0% 0% 0% 0% 0%
Gli3+/- 25 0% 0% 28% 0% 0%
Pax6+/- 16 38% 0% 0% 0% 0%
Pax6+/-; Gli3+/- 28 36% 64% 68% 39% 7%BMC Developmental Biology 2006, 6:46 http://www.biomedcentral.com/1471-213X/6/46
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in any of the other genotype groups. Large cyst-like struc-
tures were observed between the iris, retina and overlying
cornea (Fig. 5C) in one Pax6+/-; Gli3+/- eye. Some Pax6+/-;
Gli3+/- animals (9/28) showed highly dysmorphic and
dysgenic lenses, which were not observed in any of the
other genotype groups (Fig. 5D, E).
Corneal defects in Pax6+/-; Gli3+/- animals
The corneal epithelium of the Pax6+/-  eye has been
reported to be thinner than normal and the corneal
stroma is hypercellular [21,22]. We confirmed these find-
ings in our samples (Fig. 6A,C). At the gross level, no dif-
ferences were observed in the cornea between wild-type
and  Gli3+/- animals (Fig. 6A,B). Pax6+/-;  Gli3+/- animals
exhibited similar corneal abnormalities to those observed
in Pax6+/- animals (Fig. 6C,D).
Thicknesses of the corneal epithelium and corneal stroma,
centrally and peripherally, were measured for the four
genotype groups. There was no difference in both central
or peripheral corneal epithelium thickness between wild-
type and Gli3+/- eyes (Fig. 5E). As previously described
[22], the corneal epithelium of Pax6+/- eyes (n = 19) was
significantly thinner than that of wild-type (n = 16) and
Gli3+/- (n = 27) eyes, both centrally and peripherally (Fig.
6E; compared to wild-type and Gli3+/-: both P < 0.001,
Student's t-test). A similar result was observed in Pax6+/-;
Gli3+/- eyes (n = 25) (Fig. 6E; compared to wild-type and
Gli3+/-: both P < 0.001; Student's t-test). Overall, these
data suggest that loss of one copy of both Pax6 and Gli3
together does not create a corneal epithelium thinner than
that resulting from loss of Pax6 alone.
There was no difference in either central or peripheral cor-
neal stromal thickness in Pax6+/- or Gli3+/- eyes compared
to wild-type eyes (Fig. 6F). The peripheral stroma of Pax6+/
-; Gli3+/- eyes was, however, slightly thinner than that of
wild-type and Gli3+/- eyes, while the central stroma was
not different to that of wild-type eyes (Fig. 6F; compared
to wild-type: P = 0.009; compared to Gli3+/-: P = 0.016;
Student's t-tests). Thus, the mean stromal thickness (aver-
age of peripheral and central) of Pax6+/-; Gli3+/- eyes was
Corneal abnormalities in Pax6+/- and Pax6+/-; Gli3+/- eyes Figure 6
Corneal abnormalities in Pax6+/- and Pax6+/-; Gli3+/- eyes. Corneal morphology of (A) wild-type, (B) Gli3+/-, (C) Pax6+/- and (D) 
Pax6+/-; Gli3+/- animals. (C) Pax6+/- and (D) Pax6+/-; Gli3+/- eyes have a thinner corneal epithelium and more hypercellular stroma 
(arrows in C) than wild-type (A) and Gli3+/- (B) eyes. Graphs show relative thicknesses of (E) corneal epithelium and (F) corneal 
stroma of the various genotype groups. The corneal epithelium of Pax6+/- and Pax6+/-; Gli3+/- eyes was significantly thinner than 
that of wild-type and Gli3+/-eyes, both centrally and peripherally. The peripheral stroma of Pax6+/-; Gli3+/- eyes was thinner than 
that of wild-type and Gli3+/- eyes, thus making the mean stromal thickness (average of peripheral and central) of Pax6+/-; Gli3+/- 
eyes significantly less than that of wild-type, Pax6+/- and Gli3+/- eyes. * = significantly different to wild-type; † = significantly differ-
ent to Gli3+/-; ‡ = significantly different to Pax6+/-. ce, corneal epithelium; cs, corneal stroma. Scale bar = 50 μm.BMC Developmental Biology 2006, 6:46 http://www.biomedcentral.com/1471-213X/6/46
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significantly less than that of wild-type (Fig. 6F; P = 0.010,
Student's t-test), Pax6+/- (Fig. 6F; P = 0.042, Student's t-
test) and Gli3+/- (Fig. 6F; P = 0.049, Student's t-test) eyes.
Discussion
The importance of the transcription factors Pax6
[16,18,19] and Gli3[4,9,10] in eye development is
reflected in the severe eye phenotypes of homozygous
mutants, which die around the time of birth. While it is
well documented that loss of one copy of Pax6 results in
various eye defects [20-22], little is known about whether
loss of one copy of Gli3 results in eye defects. Thus, in this
study, we set out to characterise the morphology of the
Gli3+/- eye. Furthermore, because both Pax6 and Gli3 are
expressed in the optic cup/retina, lens and iris during
development [5,18,27-29], we were also interested in
whether Pax6 and Gli3 play mutually co-operative roles in
eye formation by studying animals compound hetero-
zygous for mutations in both Pax6 and Gli3.
No abnormality was observed in the majority of the Gli3+/
- eyes that we examined. Where abnormalities were seen,
they were very mild. Gli3+/- eyes had a slightly higher mass
than wild-type eyes as well as a thicker OPL compared to
wild-type retinae. Retinal folding has been described pre-
viously in some neonatal Gli3+/- animals [4]. Overall,
defects in Gli3+/- eyes are either not detectable or minor.
Animals compound heterozygous for mutations in both
Pax6  and  Gli3  exhibited unique and more severe eye
defects than either Pax6+/- or Gli3+/- animals or than would
be predicted by addition of their phenotypes. As previ-
ously described [22], the mass of Pax6+/- adult eyes was
significantly smaller than that of wild-type eyes. The addi-
tional loss of one copy of Gli3 resulted in eyes with a wide
range of eye mass, from some eyes with smaller mass than
Pax6+/- eyes to some eyes which fell within the wild-type
range of eye mass.
A range of retinal phenotypes was observed in Pax6+/-;
Gli3+/- eyes. Some Pax6+/-; Gli3+/- retinae were thinner than
normal but exhibited normal lamination while others
were severely dysgenic with considerable laminar dysmor-
phology. The severe retinal defects found in Pax6+/-; Gli3+/
- animals were never seen in either Pax6+/- or Gli3+/- ani-
mals. One mechanism by which Pax6  and  Gli3  might
cooperate during retinal development is through their
actions in the Shh signalling pathway. This pathway is
critical for normal eye development. Shh from the ventral
midline of the early neural plate stage embryo is required
for early patterning of the visual system [12]. Later, Shh is
expressed in the developing retina [30] and has been
shown to be important in photoreceptor development
and retinal lamination [13,31]. Gli3 is essential for the
transduction of Shh signalling: in the absence of Shh, the
Gli3 protein is cleaved proteolytically to produce a form
that is thought to function mainly as a repressor [32].
Lowering the gene dosage of Gli3 can partially rescue the
Shh-null phenotype [8], suggesting that reducing Gli3 lev-
els allows the partial reactivation of Shh signalling path-
ways. It is possible, therefore, that a reduced level of Gli3
in otherwise wild-type cells (i.e. in Gli3+/- mice) mimics
the effects of raising Shh levels. There is evidence that Shh
suppresses Pax6 expression [23,33], and lowered Pax6
expression is known to affect eye development. While the
loss of one copy of Gli3 (mimicking raised Shh signalling)
might not lower Pax6 levels enough to create morpholog-
ically detectable defects if both alleles of Pax6 are func-
tional, levels might fall below a critical threshold in Pax6+/
-;Gli3+/- heterozygotes. Furthermore, there is evidence that
Pax6 suppresses Shh expression [24-26] and so the
decreased levels of Pax6 in the Pax6+/-;Gli3+/- heterozy-
gotes might allow increased production of Shh, thereby
further exacerbating the overstimulation of the Shh path-
way. The mechanism by which reduced levels of the
repressor form of Gli3 result in reduced Pax6 levels might
involve loss of repression of intermediate transcription
factors such as Pax2 and Vax1, that themselves repress
Pax6 [11]. These possibilities are summarized in Fig. 7.
While an interaction in Shh signalling seems likely, there
are numerous other signalling pathways in which Gli3
and Pax6 might cooperate. A strong possibility is in
fibroblast growth factor 8 (FGF8) signalling, since both
Gli3 and Pax6 are known to regulate FGF8 expression
[29,34]
Like the defects in the retina, abnormalities in the anterior
segment of the Pax6+/-; Gli3+/- animals were more severe
than those of either Pax6+/- or  Gli3+/- animals.  Pax6+/-;
Gli3+/- animals had highly dysgenic lenses which were
Summary of possible interactions between Gli3 and Pax6 in  Shh signalling Figure 7
Summary of possible interactions between Gli3 and Pax6 in 
Shh signalling. The processing of Gli3 to its cleaved form 
(Gli3CL) from its full-length form (Gli3FL) is inhibited by Shh. 
Levels of Pax6 are regulated by levels of Gli3CL by a process 
of double repression, perhaps involving Pax2 and Vax1, such 
that lowering levels of Gli3CL lowers Pax6 levels. Pax6 nega-
tively regulates Shh expression: thus, lowered Pax6 levels 
increase Shh's repression of Gli3CL production.
Shh
Gli3FL          Gli3CL
?
Pax2
Vax1
Pax6BMC Developmental Biology 2006, 6:46 http://www.biomedcentral.com/1471-213X/6/46
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never seen in Pax6+/- or Gli3+/- animals. There were partic-
ularly high incidences of abnormal contacts involving the
iris in Pax6+/-; Gli3+/- animals and, in contrast to the iris
hypoplasia observed in Pax6+/- animals, many Pax6+/-;
Gli3+/-  animals exhibited hyperplastic irises. Together
these data suggest not only that the iris is sensitive to lev-
els of Pax6 expression but that normal Gli3 expression
may also be required, in conjunction with Pax6, for nor-
mal iris development to occur. Pax6+/-; Gli3+/- animals also
showed thinning of the corneal epithelium and disorgan-
isation of the corneal stroma, similar to that observed in
Pax6+/- animals. Unlike Pax6+/- and Gli3+/- animals, how-
ever, the peripheral corneal stroma was significantly thin-
ner than in wild-types. As Gli3+/- animals showed no
difference in the thickness of the corneal stroma, the
reduction of Gli3 dosage alone does not affect stromal
thickness but does so only in combination with reduced
Pax6 dosage.
Conclusion
We have found that animals compound heterozygous for
mutations in both Pax6 and Gli3 have eye abnormalities
that are either not present in, or are more severe than,
those present in animals heterozygous for mutations in
either gene. Addition of the phenotypes of Pax6+/- and
Gli3+/- animals is insufficient to explain the severe pheno-
types of the compound mutants. Our findings suggest that
Gli3 and Pax6 cooperate during eye morphogenesis.
Methods
Mice
The Pax6+/- (Small eye, Sey) strain was maintained on a
mixed (C57Bl/Fa, Ju/Fa and JBT/Jd) background as
described previously [35]. The Gli3+/- strain (Extra toes, XtJ)
was maintained on an inbred CBA/Ca background. Ani-
mals wild-type at the Pax6 and Gli3 loci, heterozygous for
either mutation (Pax6+/- or Gli3+/-) and compound hetero-
zygous for mutations in both genes (Pax6+/-; Gli3+/-) were
obtained by crosses between Pax6+/- and Gli3+/- animals.
65 animals from 17 litters were analyzed. All comparisons
were between wild type, Pax6+/-, Gli3+/- and Pax6+/-; Gli3+/
- siblings. Animals were killed by cervical dislocation; eyes
were removed and some were weighed before fixing for
histological preparation. All animal procedures were per-
formed in accordance with Home Office (UK) legislation.
Histology
Eyes were fixed in either 4% paraformaldehyde or Bouin's
fluid overnight before dehydrating and processing to par-
affin wax. Bouin's fluid was selected for tissue for mor-
phometric analysis as it causes few artefacts of tissue
fixation. Sections were cut at 10 μm and stained with hae-
matoxylin and eosin. Midsections through the eye con-
taining the optic nerve were identified for morphometric
retinal and corneal analysis.
Genotyping
Mutations in the Pax6 gene were assessed as described pre-
viously [35]. Mapping of the mutant Gli3XtJ allele has
revealed a 51.5-kb deletion [36]. Using a multiplex PCR
strategy [35], wild-type Gli3  and mutant Gli3XtJ alleles
were identified using the following primers: 580For 5'
TACCCCAGCAGGAGACTCAGATTAG-3' and 580Rev 5'-
AAACCCGTGGCTCAGGACAAG-3'; C3For 5'-
GGCCCAAACATCTACCAACACATAG-3' and C3Rev 5'-
GTTGGCTGCTGCATGAAGACTGAC-3' producing prod-
ucts of 193 bp and 580 bp for the wild-type and mutant
alleles respectively.
Morphometric analysis
Morphometric analysis of the retinal layers was performed
only in eye sections where normal laminar morphology of
the retina was maintained. Animals with eyes which were
severely dysplastic were not included in this analysis.
Transverse eye sections at the level of the optic nerve
(medial section) were photographed with a digital camera
at ×40. The thicknesses of the whole retina as well as the
thicknesses of the inner nuclear layer (INL), outer nuclear
layer (ONL), inner plexiform layer (IPL) and outer plexi-
form layer (OPL) were measured using ImageTool™. Two
separate measurements were taken on either side of the
optic nerve (Fig. 4A) and averaged. Statistical comparison
of layer thicknesses between genotype groups was carried
out using Sigmastat™. Student's t-tests were used to com-
pare layer thicknesses between genotype groups.
Analysis of corneal epithelial and stromal thickness was
performed essentially as described previously [22]. Serial
transverse sections of each eye were taken. The medial sec-
tion ('Section 0') of each eye was determined. Analysis of
corneal thickness was performed using a linear eye piece
graticule on three medial and near-medial sections (Sec-
tions 0, -3 and +3). The thickness (apical-basal depth) of
the corneal epithelium, stroma and the whole cornea were
measured separately at the centre and periphery of the cor-
nea on all three sections for each eye. Data from central
and peripheral regions were combined to obtain overall
mean thickness of corneal epithelium and stroma in each
eye. Statistical comparison of corneal thickness between
genotype groups was carried out using Sigmastat™. Stu-
dent's t-tests were used to compare corneal layer thickness
between genotype groups.
Immunohistochemistry
Slides were microwaved in 10 mM sodium citrate to
achieve maximal antigen retrieval before addition of pri-
mary antibody. Mouse monoclonal anti-Pax6 antibody
(1:100) was obtained from the Developmental Studies
Hybridoma Bank (University of Iowa, Department of Bio-
logical Sciences, Iowa City, IA 52242). Signal wasBMC Developmental Biology 2006, 6:46 http://www.biomedcentral.com/1471-213X/6/46
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enhanced using the Dako ABC Kit and visualised with
diaminobenzidine (DAB).
RNA in-situ hybridisation
A 611 base pair fragment comprising nucleotides 560–
1170 of the mouse Gli3 cDNA (a gift from T. Theil) was
PCR amplified and subcloned into a pGEM-Teasy vector
(Promega). The plasmid was linearized with SpeI and
transcribed with T7 RNA polymerase. Non-radioactive
RNA in-situ hybridisation on paraffin wax-embedded sec-
tions was carried out using a protocol described previ-
ously [27].
Abbreviations
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PHS Pallister-Hall Syndrome
Shh Sonic hedgehog
Xt extra-toes
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